Ekso Bionics Holdings (EKSO) Other Non-Current Liabilities (2016 - 2025)
Ekso Bionics Holdings (EKSO) has disclosed Other Non-Current Liabilities for 13 consecutive years, with $89000.0 as the latest value for Q4 2025.
- On a quarterly basis, Other Non-Current Liabilities fell 50.83% to $89000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $89000.0, a 50.83% decrease, with the full-year FY2025 number at $89000.0, down 50.83% from a year prior.
- Other Non-Current Liabilities was $89000.0 for Q4 2025 at Ekso Bionics Holdings, down from $164000.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $4.6 million in Q2 2021 to a low of $35000.0 in Q3 2024.
- A 5-year average of $760333.3 and a median of $144500.0 in 2023 define the central range for Other Non-Current Liabilities.
- Biggest YoY gain for Other Non-Current Liabilities was 11570.0% in 2021; the steepest drop was 97.65% in 2021.
- Ekso Bionics Holdings' Other Non-Current Liabilities stood at $1.5 million in 2021, then plummeted by 84.97% to $233000.0 in 2022, then surged by 57.08% to $366000.0 in 2023, then tumbled by 50.55% to $181000.0 in 2024, then plummeted by 50.83% to $89000.0 in 2025.
- Per Business Quant, the three most recent readings for EKSO's Other Non-Current Liabilities are $89000.0 (Q4 2025), $164000.0 (Q1 2025), and $181000.0 (Q4 2024).